Ignite Creation Date:
2025-12-24 @ 5:40 PM
Ignite Modification Date:
2026-03-18 @ 9:34 AM
Study NCT ID:
NCT00108368
Status:
COMPLETED
Last Update Posted:
2009-01-21
First Post:
2005-04-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Effects of Risperidone and Olanzapine on Thinking
Sponsor:
US Department of Veterans Affairs
Organization:
Study Overview
Official Title:
The Cognitive Effects of Risperidone and Olanzapine
Status:
COMPLETED
Status Verified Date:
2007-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this research is to find ways to maximize the benefits of antipsychotic medications for cognition.
Hypothesis: Risperidone and olanzapine will show greater benefits than conventional medications on assessments of social cognition, particularly affect perception and social perception.
Hypothesis: Risperidone and olanzapine will show greater benefits than conventional medications on assessments of social cognition, particularly affect perception and social perception.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: